Antiproliferative effects of Curcumin plus Centchroman in MCF-7 and MDA MB-231 cells

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 2, 2011, Pages 212-216

  Zaidi, Deeba ^a,b   Singh, Neetu ^a   Ahmad, Iffat Zareen ^b   Sharma, Ramesh ^a   Balapure, Anil K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b INTEGRAL UNIVERSITY   (India)

Author keywords

Antiproliferative; Curcumin

Indexed keywords

CENTCHROMAN; CURCUMIN; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG MEGADOSE; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LOW DRUG DOSE;

EID: 79955934971     PISSN: 09751491     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Saxena S, Agarwal U, Nadayil D, Chaudhary K, Murthy N. Changing Trends in the Incidence of Breast Cancer. Indian J Cancer 2009; 46: 73-4.
2. National Cancer Registry Programme, Time Trends in Cancer Incidence Rates 1982-2005, Indian Council of Medical Research Bulletin 2009.
3. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991; 57 (1): 1-7.
4. Senft C, Polacin M, Priester M, Seifert V, Kögel D, Weissenberge J. The nontoxic natural compound Curcumin exerts antiproliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer 2010; 10: 491.
5. Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R. Curcumininduced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 2005; 104 (4): 879-90.
6. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002; 98(2): 234-40.
7. Srivastava S, Sharma R, Balapure AK. Morphological and Biochemical Basis of Centchroman as a Novel Antineoplastic Agent in MCF-7 Human Breast Cancer Cells. Indian Journal of Pharmacology 2004; 36 (4): 238-43.
8. Nigam M, RanjanV, Srivastava S, Sharma R, Balapure AK. Centchroman Induces G0/G1 Arrest and Caspase-dependent Apoptosis Involving Mitochondrial Membrane Depolarization in MCF-7 and MDA MB-231 Human Breast Cancer Cells. Life Sci 2008; 82 (11-12): 577-590.
9. Nigam M, Singh N, Ranjan V, Zaidi D, Sharma R, Nigam D, Gupta DK, Sundaram S, Balapure AK. Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation. Life Sci 2010; 87 (23-26): 750-758.
10. Mishra NC, Nigam PK, Gupta R, Agarwal AK, Kamboj VP. Centchroman-a nonsteroidal anticancer agent for advanced breast cancer: phase II study. International Journal of Cancer 1989; 43: 781-783.
11. Tharakan ST, Inamoto T, Sung S, Aggarwal BB, Kamat AM. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem Pharmacol 2010; 79 (2): 218-228.
12. Howells LM, Mitra A, Manson MM. Comparison of oxaliplatin and curcumin-mediated antiproliferative effects in colorectal cell lines. Int J Cancer 2007; 121 (1): 175-83.
13. Kamat AM, Sethi G, Aggarwal BB. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. Mol Cancer Ther 2007; 6 (3): 1022-30.
14. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J and Aggarwal BB. Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-κB-Regulated Gene Products. Cancer Res 2007; 67(8): 3853-61.
15. Li L, Ahmed B, Mehta K, Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 2007; 6 (4): 1276-82.
16. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of Curcumin: Problems and Promises. Molecular Pharmaceutics 2007; 4 (6): 807-818
17. Soto AM, Sonnenschein, C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). Journal of Steroid Biochemistry 1985; 23 (1): 87-94.
18. Shagufta, Srivastava AK, Sharma R, Mishra R, Balapure AK, Murthy PS, Panda G Substituted phenanthrenes with basic amino side chains: a new series of anti-breast cancer agents Bioorg Med Chem. 2006; 14 (5): 1497-505.
19. Wargovich MJ. Nutrition and cancer: the herbal revolution. Curr Opin Clin Nutr Metab Care 1999; 2: 421-424.
20. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. Curcumin downregulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway. Cancer Letters 2008; 259 (1): 111-118.
21. Wolanin K, Magalska A, Mosieniak G, Klinger R, McKenna S, Vejda S, Sikora E, Piwocka K. Curcumin Affects Components of the Chromosomal Passenger Complex and Induces Mitotic Catastrophe in Apoptosis-Resistant Bcr-Abl-Expressing Cells. Mol Cancer Res 2006; 4 (7): 457-69.
22. Syng-ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Mol Cancer Ther 2004 3; 1101-18.
23. Choudhuri T, Suman Pal, Tanya Das, Gaurisankar Sa. Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1-expressed Cells at G2 Phase of Cell Cycle in a p53-dependent Manner. J Biol Chem 2005; 280: 20059-68.